How CAR T-Cell
Immunotherapy Works
In its essence, CAR T-Cell Immunotherapy utilises the body’s
natural defences to fight cancer. It does this in the following ways:
In its essence, CAR T-Cell Immunotherapy utilises the body’s natural defences to fight cancer. It does this in the following ways:
Helping the immune system
work better at finding and
destroying cancer cells.
Stopping or slowing the
growth of cancer cells
in the body.
Stopping or slowing the
spread of cancer cells
around the body.
Prolonging remissions
as CAR T-Cells can persist
in the body.
An array of non-CAR T-Cell products are also available under the Other Immunotherapy category.
Available CAR T-Cell
Immunotherapy Gene Products
IMMUNOTHERAPY GENE PRODUCT | TYPE OF CANCER |
IL13Rα2 |
|
Claudin18.2 |
|
Mesothelin |
|
GPC3 |
|
PSMA |
|
An array of non-CAR T-Cell products are also available under the Other Immunotherapy category.
The Treatment Process
Pre-Assessment
Doctor consults patient and assess their health to determine suitability for treatment.
Collection
Blood is collected from patient at a medical centre and sent to the laboratory for CAR T-Cell production.
Treatment
Patient is treated with an infusion of CAR T-Cells.
Post-Monitoring
Medical follow up or biopsy is performed on the patient to monitor progress.
STATISTICS
The Numbers Behind
CAR T-Cell Immunotherapy
The coverage area for CAR T-Cell Immunotherapy is expanding, and that means even more reasons not to give up.
THERAPEUTIC AREA
Haematological Cancer
Solid Tumour
T-Cell Immunotherapies: Development Pipeline
Distribution by Indication
As reported by the Global T-cell (CAR-T, TCR, TIL) Therapy Market (5th Edition), 2020-2030